P/E at 60.82 vs Industry's 67.65: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Discount Amidst Sector Premiums

Apollo Hospitals Enterprise Ltd. trades at a P/E multiple of 60.82, which is approximately 10.1% below the hospital sector’s average P/E of 67.65. This discount suggests that despite its large-cap stature and strong market presence, the stock is valued more conservatively relative to its peers. The sector’s elevated P/E reflects growth expectations and premium pricing for healthcare providers, yet Apollo Hospitals appears to be priced with a margin of caution. This valuation gap invites the question previously rated Buy, what is Apollo Hospitals’ current rating? The premium sector valuation contrasts with the stock’s more tempered multiple, hinting at either a relative value opportunity or underlying concerns priced in by the market.

Performance Across Timeframes: Strong Long-Term Gains, Mixed Short-Term Signals

Examining returns over various periods reveals a compelling story of resilience and recent moderation. Over the past year, Apollo Hospitals has delivered a 16.79% gain, significantly outperforming the Sensex’s decline of 9.19%. This outperformance extends over longer horizons, with three-year returns at 74.78% and five-year returns at 88.20%, dwarfing the Sensex’s respective 11.63% and 22.73% gains. The decade-long performance is even more striking, with a 565.43% return compared to the Sensex’s 157.08%, underscoring the stock’s sustained growth trajectory.

However, the short-term momentum is less robust. The three-month return stands at a modest 3.64%, while the one-month gain is only 0.32%, both outperforming the Sensex’s negative returns but indicating a slowdown in recent acceleration. The stock has experienced a two-day consecutive decline, losing 1.9% in that span, despite closing today with a marginal 0.07% increase. This short-term softness raises the question is this a temporary pause or a sign of deeper momentum loss?

Moving Average Configuration: Bullish Across All Key Averages

The technical setup for Apollo Hospitals is notably positive, with the stock trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This alignment indicates a strong upward trend across both short and long-term horizons, suggesting that despite recent minor pullbacks, the stock remains in a sustained bullish phase. The proximity to its 52-week high—just 4.94% away—further reinforces this momentum. The 2-day consecutive fall and slight intraday stagnation at Rs 8,888 do not yet undermine the broader technical strength, but is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Sector Context: Hospital Industry Shows Mixed Results

The hospital sector continues to display a mixed performance profile, with a blend of positive, flat, and negative results across constituent stocks. The sector’s elevated P/E ratio of 67.65 reflects investor optimism about growth prospects and the defensive nature of healthcare services. Within this environment, Apollo Hospitals’ valuation discount and strong relative performance stand out. The stock’s ability to outperform the Sensex consistently over multiple timeframes while maintaining a below-sector P/E ratio suggests a nuanced valuation-performance tension that investors may wish to consider carefully.

Rating Context: Previously Rated Buy, Now Reassessed

MarketsMOJO had previously assigned a Buy rating to Apollo Hospitals Enterprise Ltd.. The rating was updated on 23 Sep 2026, reflecting a reassessment of the company’s fundamentals, valuation, and technicals. While the current rating is not disclosed, the data-driven approach highlights the stock’s strong long-term performance, attractive valuation relative to its sector, and robust technical positioning. This raises the question should investors in Apollo Hospitals hold, buy more, or reconsider?

Conclusion: A Complex Valuation-Performance Dynamic

The data on Apollo Hospitals Enterprise Ltd. reveals a stock that is trading at a meaningful discount to its hospital sector peers on a P/E basis, despite delivering superior returns over one, three, five, and ten-year periods. Its technical positioning above all major moving averages and proximity to a 52-week high underscore a resilient trend. Yet, short-term performance signals a slight moderation, with recent minor declines and subdued monthly gains. The reassessment of its rating from Buy to a new status reflects this complex interplay of valuation, performance, and technical factors — what does this mean for investors looking at Apollo Hospitals today?

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today